AHR and necrotizing enterocolitis: Maternal delivery of AHR ligands, namely ligand indole-3-carbinole and A18 in this study, to the fetus may prevent the development of NEC by reducing toll-like receptor 4 (TLR4) signaling in the offspring gut and independent of leukocyte activation.